Isoleucyl-tRNA Synthetase (IARS) Peptide
Quick Overview for Isoleucyl-tRNA Synthetase (IARS) Peptide (ABIN936037)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- YEAAKVFGLR SRKLKLFLNE TQTQEITEDI PVKTLNMKTV YVSVLPTTAD
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of IARS antibody,
Alternative Names: IARS control peptide, IARS antibody Blocking Peptide, Anti-IARS Blocking Peptide, Isoleucyl-tRNA Synthetase Blocking Peptide, FLJ20736 Blocking Peptide, IARS1 Blocking Peptide, ILRS Blocking Peptide, PRO0785 Blocking Peptide -
Purification
- Affinity chromatography using phosphopeptide and cross-adsorbed with the corresponding non-phosphopeptide.
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- IARS (Isoleucyl-tRNA Synthetase (IARS))
-
Background
- Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAS, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Isoleucine-tRNA synthetase belongs to the class-I aminoacyl-tRNA synthetase family and has been identified as a target of autoantibodies in the autoimmune disease polymyositis/dermatomyositis. Two alternatively spliced variants have been isolated that represent alternate 5' UTRs.
-
Molecular Weight
- 144 kDa
Target
-